---
title: "Simvastatin - Arteriosclerotic vascular disease"
sidebar: mydoc_sidebar
permalink: simvastatinarterioscleroticvasculardisease.html
toc: false 
---

{% include image.html url="images/simvastatinarterioscleroticvasculardisease.png" file="simvastatinarterioscleroticvasculardisease.png" alt="simvastatinarterioscleroticvasculardisease" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D019821 | Simvastatin | Drug |
| UniProt:P04035 | HMG-CoA reductase | Protein |
| REACT:R-HSA-191273 | Cholesterol synthesis | Pathway |
| MESH:D002784 | Cholesterol | ChemicalSubstance |
| HP:0002621 | atherosclerotic plaque formation | PhenotypicFeature |
| MESH:D001161 | Arteriosclerotic vascular disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Simvastatin | DECREASES ACTIVITY OF | Hmg-Coa Reductase |
| Hmg-Coa Reductase | NEGATIVELY REGULATES | Cholesterol Synthesis |
| Cholesterol Synthesis | DECREASES ABUNDANCE OF | Cholesterol |
| Cholesterol | PREVENTS | Atherosclerotic Plaque Formation |
| Atherosclerotic Plaque Formation | CORRELATED WITH | Arteriosclerotic Vascular Disease |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00641#mechanism-of-action](https://go.drugbank.com/drugs/DB00641#mechanism-of-action){:target="_blank"}